Mood disorders such as bipolar disorder and major depressive disorder (MDD) have a strong genetic component.
Insights into genetic variants underlying mood disorders can help improve treatment options.
High heritability estimates for various psychiatric conditions including:
Bipolar Disorder
Schizophrenia
Major Depressive Disorder
Other conditions such as substance use disorders and anxiety disorders.
Graphical representation indicates the relative heritability of these disorders.
Karyotype shows chromosomes: 22 pairs of autosomes and sex chromosomes (XX for females, XY for males).
Findings can assist in understanding chromosomal disorders and array comparative genomic hybridization results.
Single Nucleotide Polymorphism (SNP) differences analyzed between DNA from individuals (e.g., C/T polymorphism).
The SNP variations may have significant implications for mood disorders genetics.
Association plots conducted to identify genetic loci linked to mood disorder traits.
Specific SNPs associated with neuroticism and extraversion show variances, reflective of genetic influences on psychiatric conditions.
Genetic studies highlight overlapping variants across disorders such as:
Autism Spectrum Disorder (ASD)
Attention Deficit-Hyperactivity Disorder (ADHD)
Bipolar Disorder
Major Depressive Disorder
Schizophrenia
Variants on chromosomes 3p21 and 10q24 were notable, indicating shared genetic underpinnings.
Analyzed SNP data from 33,332 cases and 27,888 controls of European ancestry.
Utilized multinomial logistic regression to explore genotype-phenotype relationships.
Conducted pathway analyses to elucidate biological correlations.
Variants identified were associated with various disorders and included genes such as:
CACNA1C and CACNB2 - L-type calcium channel subunits associated with mood disorders.
Polygenic risk scores indicated diagnostic specificity across mood disorders.
The glutamatergic system's role in BD and MDD is significant for understanding treatment pathways.
Glutamate-related genes are linked to mood disorders, with implications for treatment resistance.
GRIA3, GRIK2, GRIK4, GRM7: associations with suicidal ideation and treatment response.
Gene involvement varies, with stronger links to bipolar disorder compared to MDD.
Allostatic Load: describes the body's cumulative burden of chronic stress, impacting mood disorder development.
Healthy state: Low load leads to normal activity and neuroplasticity.
Mood Disorder state: High allostatic load results in persistent neurotoxicity and energetic imbalance.
Investigation of brain activation differences in response to CCK-4 injections in panic states, focusing on the amygdala.
Findings suggest significant insights into the neurophysiological responses underlying panic disorders.